Adrian Devitt-Lee, Project CBD’s chief science writer, is the winner of the Norbert Wiener Award in Mathematics from Tufts University, where he graduated with a MS in Math and a BA in Chemistry. He is the co-author of several articles in peer-reviewed publications, including the Journal of Physiology, F1000Research, SIAM Journal on Applied Mathematics, and Physica A. Devitt-Lee’s report on cannabinoid-pharmaceutical interactions was published in Sonoma Medicine. As a R&D intern with Medicinal Genomics, he identified mutations in the CBDA synthase gene in plant varieties. He also performed cell culture, time-lapse microscopy, flow cytometry and RNA extraction on cancer cells as an intern with the California Pacific Medical Center in San Francisco. As a senior research associate with CannaCraft, Inc., Devitt-Lee researched pesticide and solvent safety and provided regulatory input to California government officials. He is currently a chemistry researcher at the University College in London.
It is increasingly recognized that cannabidiol can moderate many of the effects of THC, but the mechanisms by which CBD does this aren’t obvious. The neurotransmitter adenosine may be one important link.
Some research has shown that caffeine can amplify the short-term forgetfulness caused by THC. A new study indicates that the caffeine may block other effect of cannabinoids.
Dosing CBD and other cannabinoids is challenging. An article in Molecules detailed the absorption and kinetics of a new formulation of self-emulsifying CBD.
Researchers from eight different countries recently collaborated on an article warning about the dangers of teens falling in love.
The protective effect of cannabinoids for those living with Type 2 diabetes and obesity is particularly pronounced among people with schizophrenia. Why?
A recent study from pharmacologists at the University of Minnesota examined how eating a meal affects the absorption of CBD.
One broad effect of CBD and THC is the stimulation of neurogenesis — the production and integration of new neurons in the brain. Researchers in Barcelona, Spain, recently studied how CBD would affect addiction and learning in mice when neurogenesis was artificially prevented.
Recent research has indicated a role of endocannabinoids in endometriosis and related diseases. A study published in Frontiers in Oncology sought to determine whether endometrial cancer could be predicted by someone’s levels of the two canonical cannabinoid receptors (CB1 and CB2) and three related fatty acids (anandamide, OEA, and PEA).
Terpenoids — the volatile compounds that give many plants their smell — appear to confer some of the medical effects of cannabis. Caryophyllene (BCP) and its derivative caryophyllene oxide (BCPO) are particularly significant terpenoids found in many green leafy vegetables.